August 25, 2021
The professor of medicine from Duke University School of Medicine discussed treatment approaches for after relapse on CAR T cell therapy or for patients who are ineligible for CAR T therapy.
August 11, 2021
Experts discuss the use and selection of CAR T therapies in relapsed/refractory diffuse large B-cell lymphoma.
July 28, 2021
Experts discussed their recommendations for second-line treatment options for patients with DLBCL.